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Routine cardiology practice includes diagnostic algorithms for thoracic aortic aneurysm 
detection at varying degrees of clinical significance. Standard procedures for evaluation and follow 
up involve screening for standard atherosclerotic risk factors, including hypertension, dyslipidemia, 
diabetes mellitus, obesity, smoking history and family history without genetic testing, as well as 
cardiac imaging techniques, such as echocardiography, computed tomography or magnetic 
resonance imaging. According to the latest reports, thoracic aortic aneurysms can present 
concomitantly with intracranial aneurysms, although the exact etiopathogenic mechanisms are not 
yet known. There is evidence that connects these two conditions with genetic predisposition, risk 
factors, and aortopathies. Routine practice does not include screening for other aneurysm locations. 
This review will highlight existing knowledge in this area and the need for further investigations.  
(Švitek L, Pušeljić N, Breškić Ćurić Ž, Selthofer-Relatić K. Aortic and Cerebral Aneurysms: Link with 
Genetic Predisposition, Risk Factors, and Aortopathies. SEEMEDJ 2019; 3(1); 29-41) 
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Introduction 
An aneurysm is defined as a focal dilatation of 
the arterial wall. The cause and pathogenesis of 
aneurysms remain unknown. The initial arterial 
dilatation appears to be caused in part by 
degeneration of a portion of the arterial wall, 
often medial elastin, followed by smooth 
muscle. In recent years, there has been greater 
evidence regarding the concomitant incidence 
of intracranial aneurysms (IAs) and aortic 
aneurysms (AAs). The prevalence of unruptured 
IAs in the general population is estimated to be 
3.2%. The prevalence of AAs, both thoracic aortic 
aneurysms (TAAs) and abdominal aortic 
aneurysms (AAAs), is around 1%–2% in the 
general population. The prevalence is higher in 
older populations at approximately 10% (1, 2).  
 The precise mechanisms of initiation, 
enlargement, or rupture of IAs, TAAs, and AAAs 
remain unknown. Biomechanical factors play 
fundamental roles in aneurysmatic 
development. An assessment of rupture 
potential should include geometry (shape and 
thickness), mechanical properties (anisotropy 
and strength), and applied loads (hemodynamic 
and perivascular), without primarily relying on 
maximum dimension. Early loss of elastin and 
subsequent loss of smooth muscle, with 
collagen structure change controlled by cellular 
responses as a result of hemodynamic and 
intramural stresses, can initiate thinning of the 
arterial wall and cause enlargement (3). 
 Congenital conditions, such as bicuspid 
aortic valve (BAV) and coarctation of the aorta 
(CoA), frequently occur with dilated aortic roots 
with a predisposition for aortic or cervical 
dissection. IAs are also more prevalent in 
patients with BAV or CoA, implying that IAs and 
aortic pathologies share a common 
developmental defect. The tunica media of both 
arteries has the same embryological origin, 
neural crest cells (NCCs), and a similar structure 
of cross-linked elastin and collagen (4, 5). 
 Another important and proposed 
pathway for aneurysm formation involves 
endothelial dysfunction and/or injury, 
inflammation, vascular smooth muscle cell 
(SMC) response, extracellular matrix 
remodeling, vessel wall ageing, and 
degeneration with end-stage death (6). These 
processes are common with atherosclerosis 
etiopathogenesis to a degree, but their 
relationship with IAs and AAs is still unknown. 
The most recent epidemiological, clinical, and 
biological evidence suggests that 
atherosclerosis and IAs/TAAs are more distinct 
than traditionally thought (7). 
 This review will focus on the concomitant 
incidence of IAs and TAAs, their 
etiopathogenesis, risk factors, genetic 
predisposition, and aortopathies. 
Artery – anatomy, histology, physiology 
and pathophysiology 
Arteries are the main conductive blood vessels 
that deliver blood from the heart to all parts of 
the body. The arterial wall consists of three 
layers: a) intima – innermost layer, consisting of 
endothelial cells attached to a basement 
membrane composed of type IV collagen and 
laminin; b) media – middle layer, built from SMCs 
embedded in extracellular matrix composed of 
elastin, collagen, and proteoglycans; and c) 
adventitia – the outermost layer, consisting of 
fibroblasts and type I collagen with admixed 
elastin. The largest arteries contain the vasa 
vasorum, a network of small vessels that supply 
large blood vessels (3). The cells and matrix of 
each layer are built to provide a structural and 
functional support to blood vessel walls (6). 
 The main difference in the structure of 
systemic arterial vasculature is the composition 
of the tunica media. According to structure, 
arteries can be divided into elastic and muscular 
arteries. The common carotid artery is an elastic 
artery, while intracranial arteries are muscular 
arteries. The absence of an external elastic 
lamina makes intracranial arteries more 
vulnerable to aneurysmatic formation and 
rupture compared to other muscular arteries. 
Each arterial site may possess a different degree 
of durability and vulnerability as a result of 
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variance in pathophysiological signals, such as 
pressure increase (8). 
 Although it may occur in any blood 
vessel, the most common aneurysms according 
to location are aneurysms of the brain (Circle of 
Willis), TAAs, and AAAs (3). Also, arterial 
bifurcations are locus minoris resistentiae for 
cerebral aneurysm formations because of 
hemodynamic stress resulting from oscillations 
in blood flow (8). According to shape, aneurysms 
can be classified as saccular or fusiform 
aneurysms. The pathogenesis of aneurysm 
formation has not yet been clarified, but it is 
assumed that initial dilatation is first caused by 
elastin degeneration in the media, followed by 
smooth muscle degeneration (3). 
Embryology 
The vascular system starts its development 
early in the third week of gestation when the first 
blood islands first appear in the umbilical vesicle. 
Blood islands are composed of mesodermal 
cells that are induced by fibroblast growth factor 
(FGF2) to differentiate into hemangioblasts, 
which are then stimulated by vascular 
endothelial growth factor (VEGF), so they 
become endothelial cells and bind into the first 
blood vessels. This is the process of 
angiogenesis (9). Another way in which blood 
vessels develop is vasculogenesis, which can 
best be explained as sprouting from pre-existing 
ones. The earliest formed primitive blood vessel 
is the dorsal aorta, which soon after becomes 
surrounded by SMCs originating from the 
splanchnic mesoderm (10). Slightly later in 
development, primary SMCs derived from the 
splanchnic mesoderm are gradually replaced by 
a secondary population of SMCs originating 
from NCCs (11-13). The thoracic aorta almost fully 
replaces its primary SMCs with neural crest-
derived SMCs (11). Conversely, the abdominal 
aorta retains its mesodermal-derived SMCs. 
SMCs derived from NCCs tend to produce a 
higher amount of elastin but at the same time 
express lower contractility function compared to 
those of mesodermal origin (14). Unique 
responses of NCCs to various cytokines and 
growth factors are firm evidence of the different 
embryonic origins of the thoracic and abdominal 
aortas. Neural crest-derived SMCs from the 
thoracic aorta show increased DNA synthesis 
and collagen production by transforming growth 
factor-β1 (TGF) as well as enhanced 
proliferation, along with synthetic activity, when 
stimulated by homocysteine. Contrary to that, 
mesodermal SMCs show no response to either 
of these (7, 8). Further support for these findings 
includes studies showing a causative link 
between the loss of signaling through TGF-β 
receptors Ι and ΙΙ and development of 
familial TAAs and dissection (15-17). The 
proposed underlying cause for this kind of 
smooth muscle distribution in the aortic wall is 
that these neural crest-derived SMCs can better 
endure the higher pulse pressure in the thoracic 
aorta by laying down more elastic lamellae 
during development and growth (10).  
 The embryological link between the 
ascending aorta and the intracranial arteries lies 
precisely in the neural crest origin of SMCs. The 
cerebrovascular structures of the face and 
forebrain are derived from pericytes and the 
musculo-connective wall of arteries from NCCs 
(18). Malposition or malfunction during the 
perturbation of these cells (neurocristopathy) 
could be a plausible cause for the simultaneous 
occurrence of AAs and IAs (19). Considering the 
different embryological origins of SMCs, Shin et 
al. showed a site-specific relationship between 
aneurysms of the aorta and intracranial arteries. 
Ascending aortic aneurysms occur more 
commonly with aneurysms of the anterior and 
middle cerebral arteries, in contrast to AAAs, 
which occur more often with internal carotid 
artery aneurysms (20). Besides the development 
of vascular structures, NCCs play an important 
role in the development of head structures, skin 
melanocytes, a great part of the peripheral 
nervous system, some endocrine cells, and 
other structures (21, 22). Waldo et al. have 
contributed to the knowledge about the 
importance of NCCs in the septation of the 
truncus arteriosus (12). Co-occurrence of 
pathologies, such as a BAV (23), CoA (24), aortic 
root dilatation, cystic medial wall degeneration, 
and cervical arterial dissection (23) all fall into the 
category of neurocristopathy phenotypes (23, 
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24). Studies have also shown higher incidence of 
IAs in neurocristopathy diseases, such as 
neurofibromatosis type 1 (25), and diseases that 
are reminiscent of neurocristopathies, such as 
Moyamoya disease, fibromuscular dysplasia, 
and cervical dissection (26). Through these types 
of head, neck, and heart pathologies, the 
importance of the participation of NCCs in 
vascular remodeling is emphasized. 
Genetic predisposition 
Given the knowledge of the common embryonic 
origin, numerous studies have focused their 
genetic research on diseases related to 
neurocristopathy phenotype (Table 1, Figure 1).  
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Figure 1. Correlation of IAs with neurocristopathy diseases 
 
Pathology in the septation of heart outflow 
tracts, such as BAV, CoA, and dilated aortic root, 
was shown to co-occur with cerebral aneurysms 
(24, 27, 28). As evidence for the same 
pathological origin, a study done by Rosenquist 
et al. showed impaired initiation of elastogenesis 
in the great vessel walls after the ablation of 
NCCs (29).  
 Considering the existing knowledge in 
embryology about the importance of TGF-β 
signaling in the development of arterial walls, it 
is easy to understand that diseases with defects 
in the TGF-β pathway show a tendency of 
aneurysm development in multiple vascular 
beds. Loeys-Dietz syndrome (mutations in 
genes encoding the TGFBR1 and TGFBR2 
receptors) (30), aneurysm-osteoarthritis 
syndrome (mutations in SMAD3, a gene 
encoding a downstream signaling mediator 
TGF-β via the TGFBR1 and TGFBR2 receptors) 
(31, 32), and Ehlers-Danlos syndrome type IV 
(mutations in the gene for the collagen type III 
pro-α-1 chain [COL3A1]) are prone to forming 
both TAAs and IAs (33). Nurmonen et al. showed 
a higher occurrence of multiple IAs in patients 
with autosomal dominant polycystic kidney 
disease. Likewise, in terms of age of occurrence 
of aneurysmal subarachnoid hemorrhage, in 
people with IAs it occurs 10 years earlier than in 
the general population (34). A study of 669 
patients with fibromuscular dysplasia showed a 
significantly higher prevalence of IAs (35). 
 Linkage studies of the entire genome 
carried out on predefined loci for three sites of 
aneurysm formation (intracranial, abdominal, 
and thoracic aorta) found five overlapping 
chromosomal regions at 3p24-25, 4q32-34, 5q, 
11q24 and 19q. 3p24–25 and 5q for the CSPG2 
gene are possible loci for IAs and TAAs. 3p24–25 
is the locus for the TGFBR2 gene, which was 
already mentioned in relation to diseases 
affecting TGF-β signaling, while CSPG2 seems 
to have an effect on the pathology of the arterial 
wall as well. For the other regions, there is no 
known candidate gene yet, but 11q24 seems to 
have a significant role in all three sites of 
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aneurysm formation, while 4q32–34 and 19q 
have an effect on aneurysms of the abdominal 
aorta and intracranial vessels (36). 
 In 2016, a mega-analysis of four 
previously published aneurysm cohort studies 
was performed (two intracerebral aneurysm 
cohort studies from the Netherlands and 
Finland, an AAA cohort study from the 
Netherlands, and a TAA cohort study from the 
United States). It detected a single nucleotide 
polymorphism at four loci (9p21, 2q33, and two 
chromosomal regions, 18q11 and 15q21) which 
showed a strong connection between IAs and 
TAAs with AAAs (37). In a study by Shin et al., 
while searching for evidence of innate 
aortopathy in patients with IAs, the scientists 
noticed that short stature was common among 
the respondents (24). The aforementioned NCCs 
have a number of roles outside the 
development of the vascular system, including a 
role in the development of the pituitary, which 
can have an effect on the growth of bone and 
cartilage (21, 38). Further research on other 
potential, unknown causes could highlight this 
problem and provide new insights in this area. 
Atherosclerosis  
Atherosclerosis correlates with arterial 
aneurysmatic occurrence. It is still unknown if it 
is a causal relationship, or if they share common 
risk factors (39). Most studies agree that 
atherosclerosis is mainly correlated with AAAs, 
but not with TAAs and IAs (3, 39-41). There is a 
shared genetic background for both AAAs and 
atherosclerosis (39, 42, 43), as well as common 
risk factors, including hypertension, obesity, 
smoking, HDL, family history, and thrombosis (2, 
20, 42, 44-51). On the other hand, some markers 
differ, such as LDL (no correlation with AAAs) 
and diabetes (negative correlation with AAAs) 
(42, 50, 51).  
 There is no conclusive evidence about 
the correlation between the development of IAs 
and atherosclerosis. Rouchaud et al. showed 
that there is no correlation between 
atherosclerosis and IAs (46). Wang et al. even 
asserted that atherosclerosis is a protective 
factor against IA rupture (52), while Hokari et al. 
suggested that middle cerebral artery 
aneurysms positively correlate with 
hypertension and cerebrovascular disease, 
which are common comorbidities in patients 
with atherosclerosis and have a higher incidence 
in stroke patients (41). Another type of IAs, 
paraclinoid aneurysms, were also the subject of 
the same study. Paraclinoid aneurysms are 
defects of an internal carotid artery wall that are 
located between the superior part of cavernous 
sinus and the entrance for the posterior 
communicating artery (53), detected with three 
dimensional time-of-flight magnetic resonance 
angiography (3D TOF MRA) in stroke patients, as 
well as in healthy adults volunteering for 
asymptomatic brain disease evaluation (41). The 
results showed that paraclinoid aneurysms have 
a lower incidence in stroke patients than in 
healthy research participants (41). Likewise, 
paraclinoid aneurysms are more affected by 
hemodynamic stress and unchangeable risk 
factors than middle cerebral artery aneurysms 
(54). These results might not mean that IAs are 
“immune to atherosclerotic risk factors”, but just 
that they are not equally affected regarding the 
localization. 
 Inflammation 
Genetics, hemodynamic changes, and 
environmental factors are the main factors in 
aneurysm development. In recent years, there 
has been considerable evidence for 
inflammation as a leading factor in the 
pathogenesis of IAs (6, 39, 55). 
 Initially, in response to hemodynamic 
stress, development of endothelial dysfunction 
is followed by an inflammatory reaction. 
Macrophages release proinflammatory 
cytokines that lead to recruitment of additional 
inflammatory cells and release matrix 
metalloproteinases (MMPs), which cause 
degradation of the extracellular matrix and 
activate other proteinases (55). According to a 
study by Aoki et al., mice with lower expression 
of monocyte chemoattractant protein-1 (MCP-1) 
and decreased accumulation of macrophages 
had a lower risk of developing cerebral 
aneurysms (56). Likewise, according to another 
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study by Aoki et al., the application of MMP 
inhibitor in rats reduced the progression of IAs 
(57). 
 MMPs cause apoptosis of SMCs, which 
are mostly concentrated in the media, leading to 
the thinning of this layer. Tumor necrosis factor-
α (TNF-α) modulates SMCs by inhibiting 
collagen synthesis, which is a predisposition for 
aneurysm formation, progression, and rupture 
(55). T cells, mast cells, and cytokines also 
participate in inflammation and aneurysm 
formation (8). TNF-α and interleukin-6 (IL-6) are 
the best explored cytokines involved in the 
development of inflammation and aneurysm 
formation. Complement activation has been 
found in patients with IAs, but it is still necessary 
to explain how it contributes to aneurysm 
formation (58). 
 According to a study by Shikata et al., 
intestinal microbiota in mice can affect the 
formation of IAs by modulating inflammation 
through depletion of macrophage infiltration 
and lowering of inflammatory cytokine levels in 
blood vessel walls (59). 
 Understanding all aspects of the role that 
inflammation plays in the formation of 
aneurysms is essential because there are many 
sites that can potentially present target sites for 
pharmacological treatment of aneurysms. Some 
agents were studied for inhibiting aneurysm 
development, such as statins, aspirin, and 
inhibitor of phosphodiesterase-4 (Ibudilast), but 
their role in the treatment has not yet been 
conclusively proved (6). 
Aorthopathy 
According to recent evidence, there are 
correlations between IAs and AAs, especially 
TAAs, which are based on an aortopathy of a 
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Regarding the prevalence of IAs, studies have 
shown similarities in groups of patients already 
known to suffer from AAs (4, 5, 20, 46). Rouchaud 
et al. conducted a study on 1081 patients with 
AAs and found the prevalence of IAs to be 11.8% 
(46). Likewise, Shin et al. carried out a study on 
611 patients with AAs and showed the 
prevalence of IAs to be 11.6% (20). In addition, 
Jung et al. searched for IAs in patients with 
dissecting AAs, and the prevalence was 13% (4). 
Furthermore, research by Kuzmik et al. 
conducted on 212 patients with TAAs showed a 
prevalence of 9.0% for IAs (60). These results 
show a much greater prevalence of IAs in 
patients with AAs, with the rate of IAs four times 
higher in patients who also have AAs (4, 20, 46) 
than in the general population.  
 TAAs and IAs do not correlate with 
atherosclerotic risk factors (2, 20, 45-49). 
Research by Rouchard et al. showed that 
coronary artery disease and hyperlipidemia 
actually lowered the odds of IAs (46). Multiple 
aneurysms in patients with IAs occur in 15–45% 
(5, 62, 63) of cases, which may suggest that 
another underlying cause increases 
susceptibility to aneurysms. 
 Another study by Shin et al. focused on 
congenital aortopathy. They identified the 
presence of BAV and CoA (5), already known 
conditions that are connected with greater 
prevalence of IAs (64-66). These are conditions 
that are usually associated with a dilated aortic 
root (5). The study showed that a group of 
people older than 55 who had large IAs (more 
than 7 mm in diameter), multiple aneurysms, or 
ruptured aneurysms had a significantly higher 
prevalence of dilated aortic roots (5). Another 
group in this study consisted of patients without 
the high-risk factors mentioned for the first 
group (5). The second group had a significantly 
higher percentage of cerebrovascular risk 
factors, such as hypertension, diabetes mellitus, 
and hyperlipidemia, as well as strokes (5). 
Similarly, a study by Egbe et al. conducted on 
678 patients with BAV showed an IA prevalence 
of 7.7% (66). In this study, the prevalence of IAs in 
patients with both BAV and CoA was 12.9% (66). 
In addition, the presence of right-left cusp fusion 
in patients with BAV was found to be a significant 
risk factor for developing IAs (66). A study by 
Schievnik et al. conducted on patients with BAV 
found that 9.8% of patients had IAs (65). In a study 
of 117 patients with CoA, Curtis et al. found the 
prevalence of IAs to be 10.3% (48). A similar study 
by Connolly et al. conducted on 100 patients 
with CoA determined that 10.0% of patients had 
IAs (64).  
 Aortic dissection is another condition that 
has been studied to evaluate its co-occurrence 
with IAs. As mentioned above, a study by 
Rouchaud et al. conducted on 71 patients found 
the prevalence of IAs to be 13% in patients with 
dissections (4). That is about four times higher 
than in the general population (4). These patients 
had hypertension and a history of 
cerebrovascular disease in numbers 
significantly higher than in the control group (4). 
This study found a significant correlation 
between the presence of IAs and the arch 
involvement seen in aortic dissection (4). 
 An additional important variable with 
influence on IA formation in patients with AAs is 
gender (4, 5, 20, 46). A few studies have shown 
that women are more prone to aneurysms 
compared to men (20, 46, 66), but this finding 
requires further research. 
Conclusion 
According to available data in the areas of 
genetics, pathophysiologic findings, risk factors, 
and aortopathies, there are strong relationships 
and predispositions for concomitant 
aneurysmatic formation in different loci. The 
embryological link between the ascending aorta 
and the intracranial arteries lies in the origin of 
SMCs or NCCs. At the developmental level, the 
septation of heart outflow tracts, such as a BAV, 
CoA, and dilated aortic root, is in direct relation 
with IAs as a result of impaired initiation of 
elastogenesis. Atherosclerosis is not a unique 
risk factor for IAs and TAAs, but is directly related 
to AAAs as well.  
 There are still many unanswered 
questions in this area in regard to the following: 
a) genetic predisposition; b) structural and 
mechanical properties: the extensive 
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differences in histology and pathophysiology, 
the cause of different shapes of IAs (saccular) 
and TAAs (fusiform), and difference between 
vessel wall structures; c) epidemiological risk 
factors between these three conditions (IAs, 
TAAs, and AAAs); d) gender differences; e) the 
impact of ageing; f) the need for further research 
and gene detection. 
 Co-occurrence of aortic and cerebral 
aneurysms exists in multiple conditions. It is not 
likely that a single genetic disorder will be found 
to explain the co-occurrence of both aneurysm 
sites. When it comes to explaining this complex 
dual pathology, the most probable 
pathophysiological explanation is that several 
levels of genetic defects, plus a multifactorial 
environmental effect, result in arterial wall 
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